Diastolic dysfunction in insulin-resistant hyperinsulinernic subjects.

被引：0
|
作者：
Zavaroni, I
Ardigò, D
Montesi, C
Massironi, P
Coruzzi, P
Piatti, PM
Monti, L
Reaven, GM
机构：
[1] Univ Parma, Dept Internal Med & Biomed Sci, I-43100 Parma, Italy
[2] Hosp San Raffaele, Metab Dis Unit, I-20132 Milan, Italy
[3] Stanford Univ, Dept Med, Stanford, CA 94305 USA
来源：
DIABETOLOGIA | 2002年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1184
引用
收藏
页码：A381 / A382
页数：2
相关论文
共 50 条
  • [31] Insulin Resistant Subjects Are at Higher Risk of Obstructive Sleep Apnea Than Equally Obese, Insulin Sensitive Subjects.
    Liu, A.
    Kushida, C.
    Reaven, G. M.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [32] The effect of rosiglitazone on endothelial dysfunction in the insulin-resistant obese Zucker rat
    Reid, JJ
    Hashem, M
    Lau, WAK
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (5-6) : A27 - A27
  • [33] Insulin resistance and endothelial dysfunction in hypertensive and atherosclerotic non-diabetic subjects.
    Bandinelli, S
    Dell'Omo, G
    Nannipieri, M
    Pucci, L
    Rizzo, L
    Marsocci, A
    Pilo, M
    Navalesi, R
    Pedrinelli, R
    Penno, G
    JOURNAL OF VASCULAR RESEARCH, 1998, 35 : 61 - 61
  • [34] Effect of troglitazone on insulin-induced vasodilation and endothelial function in insulin-resistant obese subjects
    Tack, CJJ
    Ong, KEM
    Vervoort, G
    Smits, P
    DIABETOLOGIA, 1997, 40 : 1211 - 1211
  • [35] Insulin-mediated increases in renal plasma flow are impaired in insulin-resistant normal subjects
    ter Maaten, JC
    Bakker, SJL
    Serné, EH
    Moshage, HJ
    Donker, AJM
    Gans, ROB
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2000, 30 (12) : 1090 - 1098
  • [36] Palmitate activates the hexosamine biosynthetic pathway in myotubes of insulin-sensitive and insulin-resistant subjects
    Weigert, C
    Klopfer, K
    Kausch, C
    Brodbeck, K
    Stumvoll, M
    Häring, H
    Schleicher, ED
    DIABETOLOGIA, 2002, 45 : A59 - A59
  • [37] Rosiglitazone improves cardiovascular risk factors and insulin resistance in insulin-resistant nondiabetic Brazilian subjects
    Bahia, L
    Godoy-Matos, AF
    Bottino, DA
    Dorigo, D
    Aguiar, LGK
    Villela, N
    Bouskela, E
    DIABETES, 2004, 53 : A482 - A482
  • [38] Bimagrumab, an Activin Receptor Inhibitor, Improves Body Composition and Insulin Sensitivity in Insulin-Resistant Subjects
    Garito, Tania
    Roubenoff, Ronenn
    Hompesch, Marcus
    Morrow, Linda
    Gomez, Katherine
    Rooks, Daniel
    Meyers, Charles
    Zakaria, Marjorie
    DIABETES, 2017, 66 : A281 - A281
  • [39] Familial insulin-resistant diabetes
    Vatier, Camille
    Le Dour, Caroline
    Bereziat, Veronique
    Caron-Debarle, Martine
    Lascols, Olivier
    Magre, Jocelyne
    Capeau, Jacqueline
    Vigouroux, Corinne
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2011, 15 (03): : 63 - 74
  • [40] Inflammation is the primary signature of gene expression profile in leukocytes of insulin-resistant subjects
    Ardigo, D.
    Byers, B.
    Valtuena, S.
    Franzini, L.
    Quetermous, T.
    Zavaroni, I.
    DIABETOLOGIA, 2006, 49 : 411 - 412
12345